Select Page

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
“HCV reinfection incidence and combined incidence declined in people with HIV following direct-acting antiviral introduction, suggesting reinfection has not affected elimination efforts among people with HIV in InCHEHC countries. The proportion of incident HCV cases due to reinfection was highest during periods of broad access to direct-acting antivirals, highlighting the importance of reducing ongoing risks and continuing testing in people at risk.”

Disappointing Results for U.S. Hepatitis C Clearance Cascade
“Only 34% of people with diagnosed hepatitis C virus (HCV) in the United States have achieved viral clearance, according to data from 2013 to 2022. This finding means progress is lagging far behind goals set by the Viral Hepatitis National Strategic Plan for the nation, which calls for at least 80% of people with HCV to achieve viral clearance by 2030 (MMWR Morb Mortal Wkly Rep 2023;72:716-720). “The findings are incredibly concerning,” Carolyn Wester, MD, the director of the Division of Viral Hepatitis in the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, said in an interview.”

Black People With Liver Cancer Are Less Likely To Receive Liver Transplants
“What’s more, Black patients have poorer survival outcomes compared to their racial counterparts. Following a policy change in liver transplant rules, rates of transplantation to treat liver cancer have fallen across all racial groups. But Black individuals experience the worst outcomes, including a high mortality rate, according to study findings published in JAMA Network Open.”

Clients of unregistered Montreal acupuncturist urged to get tested for hepatitis, HIV
“Montreal public health officials are urging anyone who received acupuncture-like treatment from Dashdorj Bayasgalan, also known as Dr. Ba, in the city’s Notre-Dame-de-Grâce neighbourhood to get tested for hepatitis B, hepatitis C and HIV.”